does pfizer make glp 1 drugs Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race New oral GLP-1 drugs could

For patients who do not have chronic kidney disease or cardiovascular disease but have at least three risk factors from Table 1 , SGLT-2 inhibitors decrease mortality with an NNT of 100 (95% CI, 67 to 167) over five years

They lower blood sugar, aid weight loss, and benefit cardiovascular and kidney health

Additionally, it lowered inflammation markers and fibrosis related genes, like IL6, secretory phospholipase A and matrix-metalloproteinase 9

Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N

A: GLP-1 drugs typically dont replace current medications

Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women